Similar articles

• ST-elevation myocardial infarction: New Zealand management guidelines.

  ST-Elevation Myocardial Infarction Guidelines Group; New Zealand Branch of the Cardiac Society of Australia and New Zealand. ST-Elevation Myocardial Infarction Guidelines Group, et al. N Z Med J. 2005 Oct 7;118(1223):U1679. N Z Med J. 2005. PMID: 16224503 No abstract available.
• Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review".

  Howlett M. Howlett M. MedGenMed. 2002 Feb 21;4(1):6; author reply 7. MedGenMed. 2002. PMID: 11965208 No abstract available.
• [Streptokinase treatment in Nordkapp].

  Bjøru H, Langfeldt E, Løvland A, Nordang B, Høybjør S. Bjøru H, et al. Tidsskr Nor Laegeforen. 1998 Jun 30;118(17):2632-3. Tidsskr Nor Laegeforen. 1998. PMID: 9673512 Norwegian.
• Lowering mortality in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: key prehospital and emergency room treatment strategies.

  Goldstein P, Lapostolle F, Steg G, Danchin N, Assez N, Montalescot G, Charpentier S, Wiel E, Juliard JM. Goldstein P, et al. Eur J Emerg Med. 2009 Oct;16(5):244-55. doi: 10.1097/MEJ.0b013e328329794e. Eur J Emerg Med. 2009. PMID: 19318957 Review.
• The effects of combined thrombolytic and platelet inhibitor therapy on myocardial and microvascular perfusion.

  de Lemos J. de Lemos J. Md Med. 2001 Spring;Suppl:88-9. Md Med. 2001. PMID: 11434069 Review. No abstract available.